HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Drabkin Selected Research

H Drabkin Research Topics

Disease

3Neoplasms (Cancer)
09/2004 - 03/2000
1Renal Cell Carcinoma (Grawitz Tumor)
09/2010
1Neoplasm Metastasis (Metastasis)
09/2004
1Neuroendocrine Tumors (Neuroendocrine Tumor)
09/2004
1Carcinoid Tumor (Carcinoid)
09/2004
1Carcinoma (Carcinomatosis)
09/2004
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2004
1Lymphatic Metastasis
09/2004
1Lung Neoplasms (Lung Cancer)
11/2001
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
08/2001
1Lipoma (Lipomata)
08/2001
1Leukemia
08/2001
1Genetic Translocation (Chromosomal Translocation)
08/2001

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
11/2001 - 08/2001
2Neuropilin-1IBA
11/2001 - 03/2000
1TOR Serine-Threonine KinasesIBA
09/2010
1Sirolimus (Rapamycin)FDA Link
09/2010
1Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2010
1Sorafenib (BAY 43-9006)FDA Link
09/2010
1Sunitinib (Sutent)FDA Link
09/2010
1Cadherins (E-Cadherin)IBA
09/2004
1beta CateninIBA
09/2004
1sodium bisulfiteFDA Link
11/2001
1Amino AcidsFDA Link
11/2001
1DNA (Deoxyribonucleic Acid)IBA
11/2001
1Conditioned Culture MediaIBA
11/2001
1Neuropilin-2IBA
11/2001
1Semaphorins (Semaphorin)IBA
11/2001
1Topoisomerase II InhibitorsIBA
08/2001
1ZyxinIBA
08/2001
1Topoisomerase InhibitorsIBA
08/2001
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2000

Therapy/Procedure

1Aftercare (After-Treatment)
08/2001